The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
“It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the study’s lead author and a heart expert at the Cleveland Clinic. “This is the population who needs the medicine the most,” said Lopez-Jimenez, who had no role in the study.The results were published Saturday in the New England Journal of Medicine and presented at a medical conference in Philadelphia. Novo Nordisk, the maker of Wegovy and Ozempic, has asked the U.S. Food and Drug Administration to include the heart benefits on Wegovy's label, like on Ozempic's.
The drop appeared to be fueled primarily by the difference in heart attacks, but the number of serious health complications reported were too small to tell whether the individual outcomes were caused by the drug or by chance. “It means to me that it's more than just weight loss, how this drug works,” said Gulati, who had no role in what she called a landmark study.
Nearly three-quarters of participants were men and nearly 84% were white. Gulati and others said future research needs to include more women and racial and ethnic minorities.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KSLcom - 🏆 549. / 51 Read more »
Obesity Drug Wegovy Cut Risk of Serious Heart Problems by 20 Percent Study FindsThe popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
Source: NEWSMAX - 🏆 16. / 71 Read more »
Source: 10News - 🏆 732. / 50 Read more »
Source: chicagotribune - 🏆 8. / 91 Read more »
Source: WIREDScience - 🏆 385. / 55 Read more »
Source: screenrant - 🏆 7. / 94 Read more »